作者: Lello Zolla , Sara Rinalducci , Simonetta Pupella , Gian Maria D’Amici , Giuliano Grazzini
DOI: 10.2450/2014.0053-14
关键词:
摘要: significant update of all regulatory aspects concerning transfusion medicine activities in Italy, including the establishment a nationally co-ordinated blood system consistent with autonomy regional authorities 1 . The aim was to identify homogeneous standards quality and safety nationwide In this setting, newly born Italian National Blood Centre be responsible for technical scientific related issues, (i) product self-sufficiency; (ii) safety; (iii) appropriate utilisation resources; (iv) accreditation funding activities; (v) national information system; (vi) technology assessment; (vii) external (viii) haemovigilance network; (ix) control medical products deriving from human plasma; (x) inspections controls plasma-derivative industry; (xi) education research medicine, (xii) promotion voluntary, non-remunerated, periodic donation light such an ambitious agenda, started extensive series initiatives, collaboration laboratory proteomics metabolomics at Tuscia University, Viterbo, Italy. present review summarises main outcomes joint effort, while putting results broader framework field special focus on storage red cell (RBC) concentrates. "-Omics" medicine: first contacts rendezvous